| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Revenue | $1.1B | $0.9B |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| R&D Expense | $0.1B | $0.0B |
| SG&A Expense | — | — |
| Operating Income | $0.2B | $0.1B |
| Net Income | $0.1B | $-0.0B |
| EPS (Basic) | $0.63 | $-0.13 |
| EPS (Diluted) | $0.61 | $-0.13 |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Total Assets | $5.8B | $4.6B |
| Current Assets | $0.3B | $0.4B |
| Cash & Equivalents | $0.1B | $0.2B |
| Total Liabilities | $1.9B | $1.5B |
| Current Liabilities | $0.2B | $0.1B |
| Stockholders' Equity | $3.9B | $3.1B |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Operating Cash Flow | $0.3B | $0.2B |
| Investing Cash Flow | $-0.7B | $-0.0B |
| Capital Expenditures | — | — |
| Financing Cash Flow | $0.2B | $0.0B |